Endurance Wealth Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$84K Hold
600
0.01% 286
2023
Q1
$85K Hold
600
0.01% 292
2022
Q4
$94K Hold
600
0.01% 260
2022
Q3
$74K Hold
600
0.01% 274
2022
Q2
$80K Hold
600
0.01% 279
2022
Q1
$82K Hold
600
0.01% 299
2021
Q4
$104K Hold
600
0.01% 285
2021
Q3
$87K Hold
600
0.01% 298
2021
Q2
$79K Hold
600
0.01% 312
2021
Q1
$77K Hold
600
0.01% 307
2020
Q4
$72K Hold
600
0.01% 279
2020
Q3
$69K Hold
600
0.01% 267
2020
Q2
$68K Hold
600
0.01% 275
2020
Q1
$48K Hold
600
0.01% 282
2019
Q4
$64K Hold
600
0.01% 256
2019
Q3
$64K Hold
600
0.01% 257
2019
Q2
$61K Hold
600
0.01% 252
2019
Q1
$54K Hold
600
0.01% 266
2018
Q4
$50K Hold
600
0.01% 260
2018
Q3
$65K Hold
600
0.01% 256
2018
Q2
$66K Hold
600
0.01% 252
2018
Q1
$60K Hold
600
0.01% 269
2017
Q4
$59K Hold
600
0.01% 260
2017
Q3
$56K Hold
600
0.01% 258
2017
Q2
$67K Hold
600
0.01% 250
2017
Q1
$59K Sell
600
-500
-45% -$47.7K 0.01% 257
2016
Q4
$101K Hold
1,100
0.02% 217
2016
Q3
$93K Hold
1,100
0.02% 223
2016
Q2
$90K Sell
1,100
-125
-10% -$9.52K 0.02% 218
2016
Q1
$88K Hold
1,225
0.01% 224
2015
Q4
$87K Buy
1,225
+125
+11% +$8.4K 0.02% 225
2015
Q3
$70K Sell
1,100
-50
-4% -$3.5K 0.01% 239
2015
Q2
$83K Buy
+1,150
New +$84.9K 0.01% 230

Other funds holding DGX

Endurance Wealth Management's DGX Position: Q2 2023 in Review

Endurance Wealth Management held its Quest Diagnostics (DGX) position steady in Q2 2023 at 600 shares worth $84K. The position accounts for 0.01% of the portfolio, ranked #286.

Endurance Wealth Management first reported a position in DGX in Q2 2015 and has held it in 33 quarters since. The position peaked at $104K in Q4 2021. 818 funds tracked by Wall St. Rank hold DGX as of Q2 2023.

  • Endurance Wealth Management held 600 shares of Quest Diagnostics worth $84K as of Q2 2023.
  • Endurance Wealth Management left its Quest Diagnostics share count unchanged in Q2 2023.
  • Quest Diagnostics made up 0.01% of Endurance Wealth Management's portfolio in Q2 2023, its #286 holding.
  • Endurance Wealth Management first reported a position in Quest Diagnostics in Q2 2015 and has held it in 33 quarters since.
  • Endurance Wealth Management's Quest Diagnostics position peaked at $104K in Q4 2021.
  • 818 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2023.

Based on Endurance Wealth Management's 13F filing for Q2 2023, filed 9 Aug 2023.